Vaccine for prevention of mild and moderate-to-severe influenza in children

New England Journal of Medicine

Volumn 369, Issue 26, 2013, Pages 2481-2491

  Jain, Varsha K ^a   Rivera, Luis ^b   Zaman, Khalequ ^c   Espos Jr , Roberto A ^d   Sirivichayakul, Chukiat ^f   Quiambao, Beatriz P ^e   Rivera Medina, Doris M ^h   Kerdpanich, Pirunghul ^g   Ceyhan, Mehmet ⁱ   Dinleyici, Ener C ^j   Cravioto, Alejandro ^c   Yunus, Mohammed ^c   Chanthavanich, Pornthep ^f   Limkittikul, Kriengsak ^f   Kurugol, Zafer ^k   Alhan, Emre ^l   Caplanusi, Adrian ^m   Durviaux, Serge ^m   Boutet, Philippe ^m   Ofori Anyinam, Opokua ^m   Chandrasekaran, Vijayalakshmi ^a   Dbaibo, Ghassan ⁿ   Innis, Bruce L ^a   more..

^a GLAXOSMITHKLINE   (United States)

^b Perinatology   (Dominican Republic)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^d De La Salle Health Sciences Institute   (Philippines)

^e RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^f MAHIDOL UNIVERSITY   (Thailand)

^g Royal Thai Army   (Thailand)

^h Clinical Research Department   (Honduras)

ⁱ HACETTEPE UNIVERSITY   (Turkey)

^j OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^k EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^l CUKUROVA UNIVERSITY   (Turkey)

^m GSK   (Belgium)

ⁿ AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; INFLUENZA VACCINE;

ARTICLE; BODY TEMPERATURE; BRONCHITIS; CHILD; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; CONVULSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INFLUENZA; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; LOWER RESPIRATORY TRACT INFECTION; MALE; MULTICENTER STUDY; NONHUMAN; NORMAL HUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SINGLE BLIND PROCEDURE; UNSPECIFIED SIDE EFFECT; VIRUS CULTURE;

EID: 84890902002     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1215817     Document Type: Article

References (33)

1. O'Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004;113:585-93.
2. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-9.
3. Bourgeois FT, Valim C, Wei JC, McAdam AJ, Mandl KD. Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics 2006;118(1):e1-e8.
4. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007;25:5086-96.
5. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1128-32.
6. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2012;8:CD004879.
7. Skowronski DM, Masaro C, Kwindt TL, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007;25:2842-51.
8. Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009;199:168-79.
9. Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009;199:159-67.
10. Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 2010;28:2149-56.
11. Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics 2006;118(3):e579-e585.
12. Levandowski RA, Regnery HL, Staton E, Burgess BG, Williams MS, Groothuis JR. Antibody responses to influenza B viruses in immunologically unprimed children. Pediatrics 1991;88:1031-6.
13. Vesikari T, Beran J, Durviaux S, et al. Use of real-time polymerase chain reaction (rtPCR) as a diagnostic tool for influenza infection in a vaccine efficacy trial. J Clin Virol 2012;53:22-8.
14. Beran J, Vesikari T, Wertzova V, et al. Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. J Infect Dis 2009;200:1861-9.
15. Hehme N, Künzel W, Petschke F, et al. Ten years of experience with the trivalent split-influenza vaccine, Fluarix. Clin Drug Invest 2002;22:751-69.
16. Saunders NR, Tennis O, Jacobson S, Gans M, Dick PT. Parents' responses to symptoms of respiratory tract infection in their children. CMAJ 2003;168:25-30.
17. Vesikari T, Knuf M, Wutzler P, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011;365:1406-16.
18. Jansen AG, Sanders EA, Hoes AW, van Loon AM, Hak E. Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial. J Pediatr 2008;153:764-70.
19. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis 1991;163:300-4.
20. DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012;31:49-57.
21. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012;30:1993-8.
22. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006;355:31-40.
23. Neuzil KM, Hohlbein C, Zhu Y. Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med 2002;156:986-91.
24. Langley JM, Martinez AC, Chatterjee A, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a randomized trial in children. Presented at IDWeek, San Diego, CA, October 17-21, 2012. abstract.
25. Tinoco JC, Pavia-Ruz N, Cruz-Valdez A, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus two trivalent influenza vaccines: a randomized controlled trial in adults. Presented at IDWeek, San Diego, CA, October 17-21, 2012. abstract.
26. Kieninger D, Lin W-Y, Yu CJ, et al. Immunogenicity and safety profile of a candidate inactivated quadrivalent influenza vaccine in adults and the elderly: a randomized controlled study. Presented at Influenza Vaccines for the World (IVW), Valencia, Spain, October 9-12, 2012. abstract.
27. Domachowske JB, Pankow-Culot H, Bautista M, et al. A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years. J Infect Dis 2013;207:1878-87.
28. Armstrong PK, Dowse GK, Effler PV, et al. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open 2011;1(1):e000016.
29. Baxter R, Jeanfreau R, Block SL, et al. A Phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children. Pediatr Infect Dis J 2010;29:924-30.
30. van Elden LJR, Nijhuis M, Schipper P, Schuurman R, van Loon AM. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol 2001;39:196-200.
31. Ward CL, Dempsey MH, Ring CJ, et al. Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J Clin Virol 2004;29:179-88.
32. Gooskens J, Swaan CM, Claas ECJ, Kroes ACM. Rapid molecular detection of influenza outbreaks in nursing homes. J Clin Virol 2008;41:7-12.
33. Liao RS, Tomalty LL, Majury A, Zoutman DE. Comparison of viral isolation and multiplex real-time reverse transcription-PCR for the confirmation of respiratory syncytial virus and influenza viruses detected by antigen immunoassay testing. J Clin Microbiol 2009;47:527-32.